New advances to combat type 1 diabetes

Researchers from the Lipids and Cardiovascular Pathology Group of the IIB Sant Pau, directed by Vicenta Llorente Cortés, have recently published an article in the journal Scientific Reports together with other researchers from the Endocrinology and Nutrition Service, from the Cardiac Imaging Unit at Hospital Sant Pau and from the Cardiovascular Biochemistry Group of the Institut de Recerca. The paper demonstrates the potential of the sLRP1 biomarker as a non-invasive indicator of epicardial fat in patients with type 1 diabetes.
The development of trials based on this protein could pave the way for new clinical tools for metabolic risk stratification in patients with type 1 diabetes.

“Soluble LRP1 is an independent biomarker of epicardial fat volumen in patients with type 1 diabetes mellitas”.

This website uses cookies to improve the browsing experience and perform analytical tasks. If you continue browsing, we understand that you agree our cookies policy. More information